What Makes Cellebrite DI Ltd. (CLBT) a New Strong Buy Stock [Yahoo! Finance]
Cellebrite DI Ltd. - Ordinary Shares (CLBT)
Company Research
Source: Yahoo! Finance
a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices. The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system. The power of a changing earnings picture in determining near-term stock price movements makes the Zacks rating system highly useful for individual investors, since it can be difficult to make decisions based on rating upgrades by Wall Street analysts. These are mostly driven by subjective factors that are hard to see and measure in real time. Therefore, the Zacks rating upgrade for Cellebrite DI Ltd. basically reflects positivity about its earnings outlook that could translate into buying pressure and an increase in its stock price. Most Powerful Force Impactin
Show less
Read more
Impact Snapshot
Event Time:
CLBT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CLBT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CLBT alerts
High impacting Cellebrite DI Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
CLBT
News
- Cellebrite DI Ltd. (NASDAQ: CLBT) had its price target raised by analysts at JPMorgan Chase & Co. from $22.00 to $24.00. They now have an "overweight" rating on the stock.MarketBeat
- D-Fend Solutions Raises $31M to Fortify Cyber Counter-Drone Technology and Market LeadershipPR Newswire
- Cellebrite Announces Participation in the UBS Global Technology and AI ConferenceGlobeNewswire
- Cellebrite and Relativity Deliver Solutions to Transform the Mobile Data Collection LandscapeGlobeNewswire
- Is Cellebrite (CLBT) Poised to Develop And Sell The Next Generation Of AI Analytics Tools? [Yahoo! Finance]Yahoo! Finance
CLBT
Earnings
- 11/6/24 - Beat
CLBT
Sec Filings
- 12/11/24 - Form 144
- 12/10/24 - Form 144
- 12/9/24 - Form 144
- CLBT's page on the SEC website